Hormone Journal

Comprehensive hormone panel

Also known as: hormone bloodwork, biomarker panel

Medically reviewed by Hormone Journal Editorial Team · Last reviewed 2026-05-17

A comprehensive hormone panel is a blood (or urine) test that measures multiple hormone biomarkers at once to assess endocrine function or guide hormone therapy.

What it is

A comprehensive hormone panel is a blood (or urine) test that measures multiple hormone biomarkers at once to assess endocrine function or guide hormone therapy. Rather than ordering a single hormone in isolation, clinicians group related markers — sex steroids, pituitary signaling hormones, and often thyroid hormones — so that results can be interpreted together. No single universally agreed-upon panel exists; the exact markers ordered depend on the clinical question, the patient's sex, age, and symptoms.

Causes and mechanism

Hormones work in feedback loops. For example, the pituitary gland releases follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to stimulate the gonads; the gonads respond by producing estradiol or testosterone, which in turn signals the pituitary to reduce FSH and LH output. Measuring only one point in this loop can miss the full picture. A panel captures multiple points simultaneously, making it easier to distinguish, say, primary ovarian insufficiency (high FSH, low estradiol) from hypothalamic suppression (low FSH, low estradiol). Similarly, thyroid function tests (TFTs) pair TSH — the pituitary signal — with free thyroxine (FT4) because TSH alone can be misleading when the pituitary-thyroid axis has not yet reached equilibrium after a therapy change.

Symptoms and diagnosis

Clinicians order a comprehensive hormone panel when a patient reports symptoms that could reflect multi-axis endocrine disruption: irregular or absent periods, hot flashes, low libido, fatigue, unexplained weight change, mood shifts, or infertility. A typical panel for a perimenopausal or menopausal evaluation includes estradiol, FSH, LH, total and free testosterone, sex hormone-binding globulin (SHBG — a protein that binds sex hormones and reduces their active fraction), DHEA-S (dehydroepiandrosterone sulfate, an adrenal androgen precursor), progesterone, TSH, and FT4. For monitoring hormone therapy (HT), the Endocrine Society recommends timing blood draws to reflect steady-state levels — typically at trough (just before the next dose) for injectable or patch formulations.

Specimen type matters. Serum remains the reference standard for most steroid hormones; the CDC's NHANES steroid panel uses isotope-dilution liquid chromatography–tandem mass spectrometry (ID LC-MS/MS) in serum, which is more accurate than older immunoassay methods, especially at low concentrations. Dried urine testing (DUTCH test) can capture hormone metabolites and diurnal cortisol patterns, but evidence for its clinical equivalence to serum is still accumulating.

Treatment options

The panel itself is a diagnostic tool, not a treatment. Results inform whether hormone therapy is indicated, what type (estrogen-only, combined estrogen-progesterone, testosterone, thyroid hormone), and at what dose. Follow-up panels — typically 6–12 weeks after starting or adjusting therapy — confirm that target ranges have been reached without over- or under-replacement.

When to see a clinician

Request a panel review (not just the raw numbers) with a clinician if you have symptoms of hormonal imbalance, are considering or already on hormone therapy, or have a personal or family history of thyroid disease, polycystic ovary syndrome (PCOS), or premature ovarian insufficiency. Direct-to-consumer hormone tests can provide numbers, but interpreting them without clinical context — including cycle day, time of day, and concurrent medications — frequently leads to misclassification.

FAQs

What hormones are included in a comprehensive hormone panel?

A typical panel includes estradiol, FSH, LH, total testosterone, free testosterone, SHBG, DHEA-S, progesterone, TSH, and FT4. Some clinicians add prolactin, cortisol, or insulin depending on symptoms. There is no single standardized list — the Endocrine Society and NAMS each publish condition-specific recommendations that guide which markers are most relevant.

What is the difference between a serum hormone panel and a urine (DUTCH) hormone test?

Serum panels measure circulating hormone concentrations at a single point in time and are validated against mass spectrometry reference methods used by agencies like the CDC. The DUTCH (dried urine test for comprehensive hormones) measures hormone metabolites and can capture a diurnal cortisol curve across 4–5 urine collections. A 2021 PMC study found reasonable correlation between DUTCH and serum for several steroids, but the authors noted that clinical reference ranges for urine metabolites are less established, and the test is not yet a recognized standard in major society guidelines.

How often should hormone levels be retested while on hormone therapy?

Most guidelines recommend a follow-up panel 6–12 weeks after starting or changing a hormone therapy regimen to confirm levels are within the therapeutic target range. Once stable, annual monitoring is common for most patients, though those on testosterone therapy or with complex thyroid conditions may need checks every 3–6 months. Timing relative to the dose (trough vs. peak) should be consistent between tests so results are comparable.

Can I order a comprehensive hormone panel without a doctor?

Direct-to-consumer hormone testing is available in many U.S. states, but results require clinical interpretation to be meaningful. Estradiol, for example, varies by a factor of 10 or more across a menstrual cycle, so a result drawn on the wrong cycle day can appear abnormal when it is not. A clinician can order the right markers at the right time and interpret them alongside your symptoms and medical history.

Is a comprehensive hormone panel covered by insurance?

Coverage varies by insurer and clinical indication. Tests ordered to investigate a specific symptom or diagnosis (e.g., irregular periods, suspected hypothyroidism) are more likely to be covered than panels ordered for general wellness screening. A panel of 8–12 markers billed separately can cost $200–$600 out of pocket at commercial labs; bundled panels marketed directly to consumers typically range from $150–$400 but may use immunoassay methods that are less accurate than mass spectrometry at low hormone concentrations.

Sources

All glossary termsUpdated 2026-05-17